Specificity of antibodies to type II collagen in rheumatoid arthritis

To reassess the role of autoantibodies to type II collagen in the pathogenesis of diseases, we studied antibodies from patients with rheumatoid arthritis (RA) and from patients with relapsing polychondritis for species specificity and collagen type specificity, using an improved enzyme-linked immuno...

Full description

Saved in:
Bibliographic Details
Published inArthritis and rheumatism Vol. 33; no. 10; p. 1493
Main Authors Terato, K, Shimozuru, Y, Katayama, K, Takemitsu, Y, Yamashita, I, Miyatsu, M, Fujii, K, Sagara, M, Kobayashi, S, Goto, M
Format Journal Article
LanguageEnglish
Published United States 01.10.1990
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:To reassess the role of autoantibodies to type II collagen in the pathogenesis of diseases, we studied antibodies from patients with rheumatoid arthritis (RA) and from patients with relapsing polychondritis for species specificity and collagen type specificity, using an improved enzyme-linked immunosorbent assay. Antibodies were found in the sera of 15% of the RA patients and 50% of the relapsing polychondritis patients, as well as in the cartilage of 69% of the RA patients examined. Reaction with both homologous and heterologous type II collagens was common. Analysis of 19 selected RA sera revealed that autoantibodies were generally associated with specific antibodies to some species of heterologous type II collagen. In contrast, antibodies found in 4% of the non-RA controls were specific for either bovine or chick type II collagen. These findings indicate that autoantibody formation in RA and relapsing polychondritis may occur as a result of an immune response to heterologous type II collagen. However, since RA and relapsing polychondritis patient sera differed in their reactivity with the cyanogen bromide-digested peptides, it is possible that the clinical manifestation of collagen autoimmunity might be influenced by the epitope specificity of the antibodies.
ISSN:0004-3591
DOI:10.1002/art.1780331006